10-May-2021 | Zion Market Research
Some of the major companies in cancer drugs market comprise GlaxoSmithKline, Bayer, Sanofi, Novartis, Amgen, Pfizer, Bristol-Myers Squibb, Merck, Ariad Pharmaceuticals, Celgene Corporation, Hoffmann-La Roche Ltd, Eli Lilly, Johnson and Johnson, Boehringer Ingelheim GmbH, and Teva Pharmaceuticals among others. These players are ready to place the cancer drugs market on new heights.
As per analysts at Zion Market Research, the global cancer drugs market was capitalized at almost USD 155.12 Billion in 2020 and is anticipated to create income of almost USD 292.80 Billion by 2028, developing at a CAGR of almost 9.5% from 2021 to 2028.
Growing Research And Development On Targeted & Biological Drug Treatments For The Cure Of Cancer To Have Positive Effect On Cancer Drugs Market
“Global cancer drugs market is majorly boosted by increasing cases of target disease such as breast cancer, lung cancer, and cervical cancer all over the globe,” as per analysts at Zion Market Research. Other major boosting factors are growing research and development on targeted & biological drug treatments for the cure of cancer. On the other hand, stringent regulatory policies and the high cost of drug development paired along with the potential of failure are the primary limitations that might hinder the development of the cancer drugs market.
Nevertheless, huge spending in anti-cancer drugs research paired with rising aim on personalized medicine all over the world is likely to disclose the new growth opportunities for cancer drugs market in the years to come. Rising elderly population in developed as well as developing nation is also one of the major reasons responsible for the development of cancer drugs market. In addition, various mergers and acquisitions by market players are also set to bolster the cancer drugs market. For example, in June 2018, Bayer successfully concluded the acquirement of Monsanto. Similarly, in May 2018, Boehringer Ingelheim (the second biggest animal health firm in the world) boosted its investment in China by extending the Asian Veterinary R&D (Research & Development) hub to improve its innovation and research capacity.
North America Likely To Stay The Dominating Area In The Global Cancer Drugs Market In The Years To Come
Europe, North America, Latin America, Asia-Pacific, and the Middle East & Africa are major regional sections in the global cancer drugs market. North America is likely to stay the dominating area in the years to come. Requirement for cancer drugs was uppermost in North America particularly in the U.S. Therefore, Asia Pacific is likely to be the moderate developing area in cancer drugs market in the years to come. In addition to this, the Latin America and Middle East & Africa are also likely to display moderate development for cancer drugs market in the coming years.
Browse the full “Cancer Drugs Market By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others), By Cancer Type (For Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other): Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2028.” Report at https://www.zionmarketresearch.com/report/cancer-drugs-market
The report segments the cancer drugs market into:
By Cancer therapy
By Cancer type
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651